An Open-Label, Single-Centre, Randomised, Two-Period, Crossover Study to Determine the Absolute Bioavailability of AZD6140 in Healthy Male and Female Volunteers
Study identifier:D5130C00038
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
An Open-Label, Single-Centre, Randomised, Two-Period, Crossover Study to Determine the Absolute Bioavailability of AZD6140 in Healthy Male and Female Volunteers
Medical condition
Healthy Volunteers
Phase
-
Healthy volunteers
-
Study drug
-
Sex
-
Actual Enrollment
-
Study type
Interventional
Age
-
Date
Study Start Date: 01 Mar 2007
Primary Completion Date: -
Study Completion Date: 01 May 2007
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Aug 2014 by AstraZeneca
Sponsors
AstraZeneca
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
